Denmark· DK-28106295319
NYXTHRACIS
A obiltoxaximab product containing obiltoxaximab, registered in Denmark by SFL Pharmaceuticals Deutschland GmbH. The same ATC class is registered in 3 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Obiltoxaximab is registered in 3 of 19 countries.
Countries holding a registration under ATC J06BC04 (obiltoxaximab), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 2 of them publish a price we can compare per daily dose
Obiltoxaximab · ATC J06BC04
3 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Obiltoxaximab
- Manufacturer
- SFL Pharmaceuticals Deutschland GmbH
- Country
- Denmark (DK)
- ATC code
- J06BC04
- ATC class
- Obiltoxaximab
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 2, 2026
Packs & prices · 1
- dk_varenummer28106295319
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Obiltoxaximab in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71fc3ff4-d62f-4b3b-ad86-27e92989bef7 GET /v1/drugs/71fc3ff4-d62f-4b3b-ad86-27e92989bef7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "koncentrat til infusionsvæske, opløsning",
"source": "dkma",
"strength": "100 mg/ml",
"auth_role": "MOD",
"dk_drugid": "28106295319",
"substance": "Obiltoxaximab",
"auth_procedure": "Central",
"in_medicinpriser": false,
"registration_date_serial": "44153"
}See everything about obiltoxaximab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.